User profiles for Joseph F. Standing

Joseph F Standing

Professor of Pharmacometrics, University College London
Verified email at ucl.ac.uk
Cited by 3443

[HTML][HTML] What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies

…, H Shakur-Still, RL Medcalf, JF Standing… - Blood coagulation & …, 2019 - journals.lww.com
Intravenous tranexamic acid (TXA) reduces death because of bleeding in patients with
trauma and postpartum haemorrhage. However, in some settings intravenous injection is not …

Understanding and applying pharmacometric modelling and simulation in clinical practice and research

JF Standing - British journal of clinical pharmacology, 2017 - Wiley Online Library
Understanding the dose–concentration–effect relationship is a fundamental component of
clinical pharmacology. Interpreting data arising from observations of this relationship requires …

[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …

…, DB Richards, J Dorward, DM Lowe, JF Standing… - The Lancet, 2023 - thelancet.com
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …

Pharmacokinetic studies in children: recommendations for practice and research

CIS Barker, JF Standing, LE Kelly, LH Faught… - Archives of disease in …, 2018 - adc.bmj.com
Optimising the dosing of medicines for neonates and children remains a challenge. The
importance of pharmacokinetic (PK) and pharmacodynamic (PD) research is recognised both in …

Paediatric formulations—Getting to the heart of the problem

JF Standing, C Tuleu - International journal of pharmaceutics, 2005 - Elsevier
… in a field such as cardiology where medicines are used to treat long-standing conditions. …
We also thank Rosemont Pharmaceuticals for Joe Standing's Ph.D. studentship and Pfizer …

Scaling clearance in paediatric pharmacokinetics: all models are wrong, which are useful?

…, CIS Barker, M Sharland, JF Standing - British journal of …, 2017 - Wiley Online Library
Linked Articles This article is commented on in the editorial by Holford NHG and Anderson
BJ. Why standards are useful for predicting doses. Br J Clin Pharmacol 2017; 83: 685–7. doi: …

Augmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children

PAJG De Cock, JF Standing, CIS Barker… - Antimicrobial agents …, 2015 - Am Soc Microbiol
There is little data available to guide amoxicillin-clavulanic acid dosing in critically ill
children. The primary objective of this study was to investigate the pharmacokinetics of both …

[HTML][HTML] Pharmacokinetic–pharmacodynamic modeling in pediatric drug development, and the importance of standardized scaling of clearance

…, CIS Barker, M Sharland, JF Standing - Clinical …, 2019 - Springer
Pharmacokinetic/pharmacodynamic (PKPD) modeling is important in the design and conduct
of clinical pharmacology research in children. During drug development, PKPD modeling …

Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies

…, M Sharland, P Heath, JF Standing - Journal of …, 2018 - academic.oup.com
Background Sepsis and bacterial meningitis are major causes of mortality and morbidity in
neonates and infants. Meropenem, a broad-spectrum antibiotic, is not licensed for use in …

Effect of age on the performance of bispectral and entropy indices during sevoflurane pediatric anesthesia: a pharmacometric study

A Sciusco, JF Standing, Y Sheng… - Pediatric …, 2017 - Wiley Online Library
Background Bispectral index ( BIS ) and entropy monitors have been proposed for use in
children, but research has not supported their validity for infants. However, effective monitoring …